Copyright
©The Author(s) 2023.
World J Gastroenterol. May 21, 2023; 29(19): 2950-2960
Published online May 21, 2023. doi: 10.3748/wjg.v29.i19.2950
Published online May 21, 2023. doi: 10.3748/wjg.v29.i19.2950
Table 2 Patient demographic and clinical characteristics
Variable | n (%) |
Mean age in yr | 39.5 ± 12.9 |
Male sex | 57 (79.2) |
History of smoking | 22 (30.6) |
History of upper abdominal pain | 48 (66.7) |
Endoscopic finding | |
Gastritis | 39 (54.2) |
Gastric ulcer | 24 (33.3) |
Duodenitis | 9 (12.5) |
Co-morbid conditions | |
Liver cirrhosis | 15 (20.8) |
Diabetes mellitus | 9 (12.5) |
Hypertension | 3 (4.2) |
cagA | 36 (50.0) |
vacA | 60 (83.3) |
s1 | 42 (58.3) |
s2 | 18 (25.0) |
m1 | 27 (37.5) |
m2 | 33 (45.8) |
- Citation: Asaad AM, El-Azab G, Abdelsameea E, Elbahr O, Kamal A, Abdel-Samiee M, Abdelfattah A, Abdallah H, Maher D, El-Refaie A, Ghanem SE, Ansari S, Awad SM. Susceptibility patterns and virulence genotypes of Helicobacter pylori affecting eradication therapy outcomes among Egyptian patients with gastroduodenal diseases. World J Gastroenterol 2023; 29(19): 2950-2960
- URL: https://www.wjgnet.com/1007-9327/full/v29/i19/2950.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i19.2950